Literature DB >> 14668799

Altered interaction of HDAC5 with GATA-1 during MEL cell differentiation.

Kouichi Watamoto1, Masayuki Towatari, Yukiyasu Ozawa, Yasuhiko Miyata, Mitsunori Okamoto, Akihiro Abe, Tomoki Naoe, Hidehiko Saito.   

Abstract

The transcription factor GATA-1 plays a significant role in erythroid differentiation and association with CBP stimulates its activity by acetylation. It is possible that histone deacetylases (HDACs) repress the activity of GATA-1. In the present study, we investigated whether class I and class II HDACs interact with GATA-1 to regulate its function and indeed, GATA-1 is directly associated with HDAC3, HDAC4 and HDAC5. The expression profiling and our previous observation that GATA-2 interacts with members of the HDAC family prompted us to investigate further the biological relevance of the interaction between GATA-1 and HDAC5. Coexpression of HDAC5 suppressed the transcriptional potential of GATA-1. Our results demonstrated that GATA-1 and HDAC5 colocalized to the nucleus of murine erythroleukemia (MEL) cells. Furthermore, a portion of HDAC5 moved to the cytoplasm concomitant with MEL cell erythroid differentiation, which was induced by treatment with N,N'-hexamethylenebisacetamide. These observations support the suggestion that control of the HDAC5 nucleocytoplasmic distribution might be associated with MEL cell differentiation, possibly through regulated GATA-1 transactivation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668799     DOI: 10.1038/sj.onc.1206902

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

Review 1.  Important roles of reversible acetylation in the function of hematopoietic transcription factors.

Authors:  Xiaofang Huo; Junwu Zhang
Journal:  J Cell Mol Med       Date:  2005 Jan-Mar       Impact factor: 5.310

Review 2.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

Review 3.  Unconventional Approaches to Modulating the Immunogenicity of Tumor Cells.

Authors:  Laurence Booth; Jane L Roberts; John Kirkwood; Andrew Poklepovic; Paul Dent
Journal:  Adv Cancer Res       Date:  2018-01-03       Impact factor: 6.242

Review 4.  Anticancer potential of the histone deacetylase inhibitor-like effects of flavones, a subclass of polyphenolic compounds: a review.

Authors:  Prabhat Singh; Raghuvir Singh Tomar; Srikanta Kumar Rath
Journal:  Mol Biol Rep       Date:  2015-06-02       Impact factor: 2.316

5.  TLX1/HOX11-induced hematopoietic differentiation blockade.

Authors:  I Riz; S S Akimov; S S Eaker; K K Baxter; H J Lee; L Mariño-Ramírez; D Landsman; T S Hawley; R G Hawley
Journal:  Oncogene       Date:  2007-01-08       Impact factor: 9.867

Review 6.  Histone deacetylases: a saga of perturbed acetylation homeostasis in cancer.

Authors:  Sabnam Parbin; Swayamsiddha Kar; Arunima Shilpi; Dipta Sengupta; Moonmoon Deb; Sandip Kumar Rath; Samir Kumar Patra
Journal:  J Histochem Cytochem       Date:  2013-09-18       Impact factor: 2.479

7.  Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation.

Authors:  Evgenya Y Popova; Sharon Wald Krauss; Sarah A Short; Gloria Lee; Jonathan Villalobos; Joan Etzell; Mark J Koury; Paul A Ney; Joel Anne Chasis; Sergei A Grigoryev
Journal:  Chromosome Res       Date:  2009-01-27       Impact factor: 5.239

8.  HDAC5 promotes osteosarcoma progression by upregulation of Twist 1 expression.

Authors:  Jie Chen; Jun Xia; Yong-lin Yu; Si-qun Wang; Yi-bing Wei; Fei-yan Chen; Gang-yong Huang; Jing-sheng Shi
Journal:  Tumour Biol       Date:  2013-10-05

Review 9.  A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.

Authors:  Lillianne H Wright; Donald R Menick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-20       Impact factor: 4.733

10.  FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases.

Authors:  Yan G Ni; Na Wang; Dian J Cao; Nita Sachan; David J Morris; Robert D Gerard; Makoto Kuro-O; Beverly A Rothermel; Joseph A Hill
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.